BJDX - CIK 0001704287
Bluejay Diagnostics, Inc. (BJDX) reported net income of -$6.85M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$6.85M | +11.3% |
| FY 2024 | -$7.72M | +22.5% |
| FY 2023 | -$9.95M | -7.1% |
| FY 2022 | -$9.30M | -166.5% |
| FY 2021 | -$3.49M | -201.2% |
| FY 2020 | -$1.16M | - |
Bluejay Diagnostics, Inc. (BJDX) reported net income of -$6.85M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Bluejay Diagnostics, Inc.'s net income declined from -$1.16M to -$6.85M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.